1. Home
  2. GB vs AVBP Comparison

GB vs AVBP Comparison

Compare GB & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GB
  • AVBP
  • Stock Information
  • Founded
  • GB 1980
  • AVBP 2021
  • Country
  • GB Switzerland
  • AVBP United States
  • Employees
  • GB N/A
  • AVBP N/A
  • Industry
  • GB EDP Services
  • AVBP
  • Sector
  • GB Technology
  • AVBP
  • Exchange
  • GB Nasdaq
  • AVBP NYSE
  • Market Cap
  • GB 1.0B
  • AVBP 948.5M
  • IPO Year
  • GB N/A
  • AVBP 2024
  • Fundamental
  • Price
  • GB $5.20
  • AVBP $35.28
  • Analyst Decision
  • GB Buy
  • AVBP Strong Buy
  • Analyst Count
  • GB 1
  • AVBP 5
  • Target Price
  • GB $6.00
  • AVBP $36.80
  • AVG Volume (30 Days)
  • GB 41.8K
  • AVBP 129.8K
  • Earning Date
  • GB 11-22-2024
  • AVBP 11-15-2024
  • Dividend Yield
  • GB N/A
  • AVBP N/A
  • EPS Growth
  • GB N/A
  • AVBP N/A
  • EPS
  • GB 0.13
  • AVBP N/A
  • Revenue
  • GB $477,415,622.00
  • AVBP N/A
  • Revenue This Year
  • GB $19.76
  • AVBP N/A
  • Revenue Next Year
  • GB $11.20
  • AVBP N/A
  • P/E Ratio
  • GB $40.81
  • AVBP N/A
  • Revenue Growth
  • GB 27.36
  • AVBP N/A
  • 52 Week Low
  • GB $4.10
  • AVBP $14.35
  • 52 Week High
  • GB $5.94
  • AVBP $36.20
  • Technical
  • Relative Strength Index (RSI)
  • GB 43.27
  • AVBP 75.00
  • Support Level
  • GB $5.46
  • AVBP $28.50
  • Resistance Level
  • GB $5.82
  • AVBP $32.01
  • Average True Range (ATR)
  • GB 0.29
  • AVBP 1.56
  • MACD
  • GB -0.02
  • AVBP 0.35
  • Stochastic Oscillator
  • GB 22.19
  • AVBP 99.48

About GB Global Blue Group Holding AG

Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: